chr12-45339639-C-T
Variant names: 
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_001025356.3(ANO6):c.280-7383C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.192 in 151,972 control chromosomes in the GnomAD database, including 3,331 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
 Genomes: 𝑓 0.19   (  3331   hom.,  cov: 32) 
Consequence
 ANO6
NM_001025356.3 intron
NM_001025356.3 intron
Scores
 2
Clinical Significance
 Not reported in ClinVar 
Conservation
 PhyloP100:  0.847  
Publications
6 publications found 
Genes affected
 ANO6  (HGNC:25240):  (anoctamin 6) This gene encodes a multi-pass transmembrane protein that belongs to the anoctamin family. This protein is an essential component for the calcium-dependent exposure of phosphatidylserine on the cell surface. The scrambling of phospholipid occurs in various biological systems, such as when blood platelets are activated, they expose phosphatidylserine to trigger the clotting system. Mutations in this gene are associated with Scott syndrome. Alternatively spliced transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Mar 2011] 
ANO6 Gene-Disease associations (from GenCC):
- Scott syndromeInheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet, ClinGen, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.65). 
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.448  is higher than 0.05. 
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes  0.192  AC: 29208AN: 151854Hom.:  3336  Cov.: 32 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
29208
AN: 
151854
Hom.: 
Cov.: 
32
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome  0.192  AC: 29197AN: 151972Hom.:  3331  Cov.: 32 AF XY:  0.196  AC XY: 14589AN XY: 74288 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
29197
AN: 
151972
Hom.: 
Cov.: 
32
 AF XY: 
AC XY: 
14589
AN XY: 
74288
show subpopulations 
African (AFR) 
 AF: 
AC: 
3638
AN: 
41492
American (AMR) 
 AF: 
AC: 
2558
AN: 
15250
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
667
AN: 
3466
East Asian (EAS) 
 AF: 
AC: 
1594
AN: 
5158
South Asian (SAS) 
 AF: 
AC: 
2237
AN: 
4818
European-Finnish (FIN) 
 AF: 
AC: 
2548
AN: 
10558
Middle Eastern (MID) 
 AF: 
AC: 
74
AN: 
294
European-Non Finnish (NFE) 
 AF: 
AC: 
15292
AN: 
67918
Other (OTH) 
 AF: 
AC: 
457
AN: 
2108
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.503 
Heterozygous variant carriers
 0 
 1179 
 2358 
 3536 
 4715 
 5894 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
 0 
 346 
 692 
 1038 
 1384 
 1730 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
Alfa 
 AF: 
Hom.: 
Bravo 
 AF: 
Asia WGS 
 AF: 
AC: 
1143
AN: 
3466
ClinVar
Not reported inComputational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 BayesDel_noAF 
 Benign 
 DANN 
 Benign 
 PhyloP100 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.